Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
ADA Guidelines Urge Routine Diabetes Screening for Liver Disease

ADA Guidelines Urge Routine Diabetes Screening for Liver Disease

New standards recommend MASLD evaluation using FIB-4 scoring and elastography to prevent serious liver complications

Naveen Sankar S's avatar
Naveen Sankar S
Jun 28, 2025
∙ Paid
4

Share this post

Just Healthcare
Just Healthcare
ADA Guidelines Urge Routine Diabetes Screening for Liver Disease
2
Share
Generated image

Topline

The American Diabetes Association (ADA) now recommends routine screening for metabolic dysfunction-associated steatotic liver disease (MASLD) among all adults with type 2 diabetes and prediabetes, emphasizing the use of noninvasive tools like FIB-4 scoring and transient elastography to detect early liver damage and initiate appropriate interventi…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share